ArticleOPEN ACCESS

Evolution: IMiDs to PPMs, revolution in DLBCL?

Blood
DOI: 10.1182/blood-2015-06-649483
4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Hagner et al provide preclinical evidence that CC-122 might be active in both major molecular subtypes of diffuse large B-cell lymphoma (DLBCL).

Cite

CITATION STYLE

APA

Nowakowski, G. S. (2015, August 6). Evolution: IMiDs to PPMs, revolution in DLBCL? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-06-649483

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free